Invention Grant
- Patent Title: Substituted piperazines as selective HDAC1,2 inhibitors
-
Application No.: US16997025Application Date: 2020-08-19
-
Publication No.: US11542242B2Publication Date: 2023-01-03
- Inventor: John H. van Duzer , Ralph Mazitschek
- Applicant: REGENACY PHARMACEUTICALS, INC.
- Applicant Address: US MA Waltham
- Assignee: REGENACY PHARMACEUTICALS, INC.
- Current Assignee: REGENACY PHARMACEUTICALS, INC.
- Current Assignee Address: US MA Waltham
- Agency: Lathrop GPM LLP
- Agent Brian C. Trinque; Nicole Sassu
- Main IPC: A61K31/495
- IPC: A61K31/495 ; C07D295/04 ; C07D295/155 ; A61P35/02 ; C07D405/12 ; C07D401/12 ; C07D213/82 ; C07D409/12 ; C07D333/20 ; C07D307/52 ; C07D213/40 ; C07D417/12 ; C07D277/56 ; C07D413/12 ; C07D263/48 ; A61P35/00 ; A61P7/00 ; C07D215/48 ; C07D401/04 ; C07D401/14 ; C07D405/14 ; C07D409/14 ; C07D413/04 ; C07D417/14
Abstract:
Provided herein are compounds of Formula IV, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat diseases or disorders associated with HDAC1 and/or HDAC2 activity.
Public/Granted literature
- US20200377465A1 SUBSTITUTED PIPERAZINES AS SELECTIVE HDAC1,2 INHIBITORS Public/Granted day:2020-12-03
Information query
